AI-Powered wristband aims to quiet essential tremor without drugs

NCT ID NCT06235190

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a wrist-worn device called Felix that uses artificial intelligence to deliver gentle nerve stimulation, aiming to reduce hand tremors in people with essential tremor. Participants wear the device daily for up to 90 days and are compared to a group using a sham (inactive) device. The goal is to see if the device safely improves tremor-related daily activities and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Felix NeuroAI Wristband (transcutaneous neurostimulation device)
What this could lead to
If it works, this could offer a noninvasive, drug-free option for managing essential tremor throughout the day.
What could go wrong
This is an early-stage study with a sham comparison, so results may not confirm lasting benefit. The device may not work for everyone, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL TREMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barrow Neurological Institute

    Phoenix, Arizona, 85013, United States

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

  • Houston Methodist Research Institute

    Houston, Texas, 77030, United States

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida, 33486, United States

  • Parkinson's Research Centers of America - Long Island

    Commack, New York, 11725, United States

  • Parkinson's Research Centers of America - Palo Alto

    Palo Alto, California, 94301, United States

  • Sir Run Run Shaw Hospital

    Hangzhou, Zhejiang, 310016, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310003, China

  • The University Of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • Tianjin Medical University General Hospital

    Tianjin, 300052, China

  • University of Cincinnati

    Cincinnati, Ohio, 45221, United States

  • Xuanwu Hospital Capital Medical University

    Beijing, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.